Diabetes · Raleigh area, NC
Diabetes studies in Raleigh area, NC
25 recruiting studies have a site in the Raleigh area. This page includes nearby cities such as Durham, Chapel Hill, Cary, Morrisville.
25 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1Overnight stay mentioned
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
GentiBio, Inc
- Location
- Chapel Hill, NC + 8 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
David D'Alessio, M.D.
- Location
- Durham, NC
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteers
Assessment of AI Program 'DRISTi' as a Screening Tool
Artelus AI
- Location
- Oxford, NC + 1 other US site
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Merck Sharp & Dohme LLC
- Location
- Wake Forest, NC + 27 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Chapel Hill, NC + 11 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Boehringer Ingelheim
- Location
- Wake Forest, NC + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Morehead City, NC + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1/Phase 2
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Boehringer Ingelheim
- Location
- Wake Forest, NC + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Asheville, NC + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Asheville, NC + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 2
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Sparrow Pharmaceuticals
- Location
- Chapel Hill, NC + 60 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1…
Aqua Medical, Inc.
- Location
- Chapel Hill, NC + 3 other US sites
- Eligibility basics
- Ages 22–65
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Raleigh, NC + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Durham, NC + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
AstraZeneca
- Location
- Raleigh, NC + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Chapel Hill, NC + 39 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
Piomic Medical
- Location
- Chapel Hill, NC + 24 other US sites
- Eligibility basics
- Ages 22–90
- RecruitingPhase 4
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
HealthTech Wound Care
- Location
- Cary, NC + 9 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.
- Location
- Durham, NC
- Eligibility basics
- Ages 18–75
- Recruiting
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Tides Medical
- Location
- Raleigh, NC + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Intraoperative OCT Guidance of Intraocular Surgery II
Duke University
- Location
- Durham, NC
- Eligibility basics
- Ages 1 mo+
- RecruitingHealthy volunteers
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
National Institute of Environmental Health Sciences (NIEHS)
- Location
- Research Triangle Park, NC
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
Personalized Environment and Genes Study
National Institute of Environmental Health Sciences (NIEHS)
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–120
- RecruitingHealthy volunteers
A Food As Medicine Approach to Address Food Insecurity in Rural North Carolina
North Carolina State University
- Location
- Raleigh, NC
- Eligibility basics
- Ages 8–64
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.